Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Uehara%2C+Yuji%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Uehara%2C+Yuji%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Uehara%2C+Yuji%22&type=Person&sort=year
PubPharm (13)
1
Brief Report : Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC
enthalten in:
JTO clinical and research reports
| 2024
von
Hirata, T.
|
Uehara, Y.
|
Hakozaki, T.
| +5
Wird geladen...
2
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy
enthalten in:
International journal of clinical oncology
| 2024
von
Terashima, Y.
|
Hakozaki, T.
|
Uehara, Y.
| +4
Wird geladen...
3
Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital
enthalten in:
JAMA network open
| 2023
von
Uehara, Y.
|
Koyama, T.
|
Katsuya, Y.
| +8
Wird geladen...
4
Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung With Sequential ALK Inhibitors : A Case Report
enthalten in:
JTO clinical and research reports
| 2023
von
Kobayashi, T.
|
Uehara, Y.
|
Watanabe, K.
| +2
Wird geladen...
5
Molecular mechanism and clinical outcome of non-small cell lung cancer patients with high BRAF expression
enthalten in:
Translational lung cancer research
| 2023
von
Uehara, Y.
CommentOn: Transl Lung Cancer Res. 2023 Jan 31;12(1):27-41. - PMID 36762067
Wird geladen...
6
Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer
enthalten in:
Translational lung cancer research
| 2023
von
Uehara, Y.
|
Hakozaki, T.
CommentOn: Transl Lung Cancer Res. 2022 Dec;11(12):2412-2417. - PMID 36636412
Wird geladen...
7
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations
enthalten in:
Thoracic cancer
| 2022
von
Uehara, Y.
|
Watanabe, K.
|
Hakozaki, T.
| +2
Wird geladen...
8
Efficacy of first‐line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations
enthalten in:
Thoracic Cancer
| 2022
von
Uehara, Y.
|
Watanabe, K.
|
Hakozaki, T.
| +2
Wird geladen...
9
Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy
enthalten in:
Translational lung cancer research
| 2022
von
Uehara, Y.
|
Hakozaki, T.
|
Kitadai, R.
| +6
Wird geladen...
10
High-resolution crystal structure of peptidyl-tRNA hydrolase from Thermus thermophilus
enthalten in:
Proteins
| 2019
von
Matsumoto, A.
|
Uehara, Y.
|
Shimizu, Y.
| +3
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
13
Aufsätze
12
E-Artikel
12
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
3
Translational lung cancer research
2
European journal of haematology
2
JTO clinical and research reports
1
Internal medicine (Tokyo, Japan)
1
International journal of clinical oncology
1
JAMA network open
1
Proteins
1
Thoracic Cancer
1
Thoracic cancer
Alle anzeigen ...
weniger ...
Thema
8
Journal Article
2
Case Reports
2
Comment
2
Durvalumab
2
EC 2.7.10.1
2
EC 2.7.11.1
2
Editorial
2
KIT
2
Research Support, Non-U.S. Gov't
2
dog
2
imatinib
2
immunotherapy
2
neoplastic mast cells
2
non-small cell lung cancer (NSCLC)
2
prognosis
2
resistance
1
28X28X9OKV
1
8A1O1M485B
1
9014-25-9
1
ALK fusion
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
9
2020-
4
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...